EcoDrugPlus

Protein Kinase D1

Ensembl ID : ENSOTSG00005046422
Gene Symbol: PRKD1
3 Cross references
198 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOTSG00005001003
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOTSG00005016162
Gene Symbol: PRKD3
3 Cross references
203 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOTSG00005040270
Gene Symbol: PRKD3
1 Cross references
195 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOTSG00005016531
Gene Symbol: PRKD3
1 Cross references
195 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSOTSG00005044311
Gene Symbol: PRKDC
1 Cross references
183 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSOTSG00005043763
Gene Symbol: PRKDC
1 Cross references
183 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSOTSG00005001494
Gene Symbol: PPP3CA
1 Cross references
228 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSOTSG00005047806
Gene Symbol: PPP3CA
1 Cross references
228 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSOTSG00005042626
Gene Symbol: PTPN11A
1 Cross references
245 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSOTSG00005008974
Gene Symbol: PTPRB
1 Cross references
197 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSOTSG00005029780
Gene Symbol: PTPRB
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).